Found: 90
Select item for more details and to access through your institution.
Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicin.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Cutaneous Myeloid Metaplasia with Dysplastic Features in Idiopathic Myelofibrosis.
- Published in:
- International Journal of Dermatology, 1988, v. 27, n. 3, p. 179, doi. 10.1111/j.1365-4362.1988.tb04926.x
- By:
- Publication type:
- Article
Update on Recommendations for Assessing Response from the Third International Workshop on Waldenström's Macroglobulinemia.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 6, n. 5, p. 380, doi. 10.3816/clm.2006.n.013
- By:
- Publication type:
- Article
Gene Expression Analysis of the Bone Marrow Microenvironment Reveals Distinct Immunotypes in Smoldering Multiple Myeloma Associated to Progression to Symptomatic Disease.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.792609
- By:
- Publication type:
- Article
Bortezomib: A valuable new antineoplastic strategy in multiple myeloma.
- Published in:
- Acta Oncologica, 2005, v. 44, n. 5, p. 440, doi. 10.1080/02841860510030002
- By:
- Publication type:
- Article
Treatment Approaches for Relapsing and Refractory Multiple Myeloma.
- Published in:
- Acta Oncologica, 2000, v. 39, n. 7, p. 843, doi. 10.1080/028418600750063604
- By:
- Publication type:
- Article
Monoclonal gammopathy of undetermined significance: a contraindication for living kidney donation?
- Published in:
- NDT Plus, 2011, v. 4, n. 4, p. 256
- By:
- Publication type:
- Article
Cross-resistance to alkylating agents in multiple myeloma.
- Published in:
- 1983
- By:
- Publication type:
- journal article
Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 2, p. 187, doi. 10.1111/bjh.18502
- By:
- Publication type:
- Article
Real‐world data on survival improvement in patients with multiple myeloma treated at a single institution over a 45‐year period.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. 649, doi. 10.1111/bjh.17888
- By:
- Publication type:
- Article
Patient‐reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. 639, doi. 10.1111/bjh.17887
- By:
- Publication type:
- Article
Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 299, doi. 10.1111/bjh.17138
- By:
- Publication type:
- Article
Complement as the enabler of carfilzomib‐induced thrombotic microangiopathy.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 1, p. 181, doi. 10.1111/bjh.16796
- By:
- Publication type:
- Article
Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1‐acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM group.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 522, doi. 10.1111/bjh.16788
- By:
- Publication type:
- Article
Prevalence and prognosis implication of MYD88 L265P mutation in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenstrom macroglobulinaemia.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 5, p. 849, doi. 10.1111/bjh.14266
- By:
- Publication type:
- Article
Phase I/II study of weekly PM00104 (Zalypsis<sup>®</sup>) in patients with relapsed/refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 4, p. 625, doi. 10.1111/bjh.13515
- By:
- Publication type:
- Article
A phase II trial of lenalidomide, dexamethasone and cyclophosphamide for newly diagnosed patients with systemic immunoglobulin light chain amyloidosis.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 6, p. 804, doi. 10.1111/bjh.13500
- By:
- Publication type:
- Article
Extramedullary disease in multiple myeloma in the era of novel agents.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Evaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myeloma.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 2, p. 223, doi. 10.1111/bjh.12519
- By:
- Publication type:
- Article
Expression of p53 protein isoforms predicts survival in patients with multiple myeloma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. 700, doi. 10.1002/ajh.26507
- By:
- Publication type:
- Article
TRATAMIENTO DEL MIELOMA MÚLTIPLE: Comentario Estudio POLLUX.
- Published in:
- El Farmacéutico Hospitales, 2018, n. 213, p. 30
- By:
- Publication type:
- Article
Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 12, p. 2997, doi. 10.1007/s00277-021-04653-2
- By:
- Publication type:
- Article
Differential humoral responses against heat-shock proteins after autologous stem cell transplantation in multiple myeloma.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 1, p. 107, doi. 10.1007/s00277-013-1942-7
- By:
- Publication type:
- Article
Re: When You Look Matters: The Effect of Assessment Schedule on Progression-Free Survival.
- Published in:
- 2008
- By:
- Publication type:
- Letter
A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis.
- Published in:
- Cancers, 2024, v. 16, n. 9, p. 1689, doi. 10.3390/cancers16091689
- By:
- Publication type:
- Article
Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution.
- Published in:
- Cancers, 2023, v. 15, n. 21, p. 5261, doi. 10.3390/cancers15215261
- By:
- Publication type:
- Article
Treatment of Patients with Monoclonal Gammopathy of Clinical Significance.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5131, doi. 10.3390/cancers13205131
- By:
- Publication type:
- Article
Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4924, doi. 10.3390/cancers13194924
- By:
- Publication type:
- Article
Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2055, doi. 10.3390/cancers13092055
- By:
- Publication type:
- Article
Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3615, doi. 10.3390/cancers12123615
- By:
- Publication type:
- Article
Pegylated Liposomal Doxorubicin plus Bortezomib in Relapsed or Refractory Multiple Myeloma: Efficacy and Safety in Patients with Renal Function Impairment.
- Published in:
- Clinical Lymphoma & Myeloma, 2008, v. 8, n. 6, p. 352
- By:
- Publication type:
- Article
Increased Serum Tumor Markers (CA125 and CA15.3) in Primary Plasma Cell Leukemia: A Case Report and Review of the Literature.
- Published in:
- Clinical Lymphoma & Myeloma, 2008, v. 8, n. 5, p. 312
- By:
- Publication type:
- Article
Lipase-catalysed synthesis of natural ethanol esters: effect of water removal on enzyme reutilisation.
- Published in:
- Journal of Chemical Technology & Biotechnology, 2000, v. 75, n. 11, p. 991, doi. 10.1002/1097-4660(200011)75:11<991::AID-JCTB322>3.0.CO;2-Q
- By:
- Publication type:
- Article
An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment.
- Published in:
- Therapeutic Advances in Hematology, 2022, v. 13, p. 1, doi. 10.1177/20406207221088458
- By:
- Publication type:
- Article
Acquired Fanconi Syndrome Secondary to Monoclonal Gammopathies: A Case Series From a Single Center.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 5, p. 614, doi. 10.1016/j.clml.2013.04.008
- By:
- Publication type:
- Article
Efficacy and safety of pegylated liposomal doxorubicin in combination with bortezomib for multiple myeloma: effects of adverse prognostic factors on outcome.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Efficacy and Safety of Pegylated Liposomal Doxorubicin in Combination With Bortezomib for Multiple Myeloma: Effects of Adverse Prognostic Factors on Outcome.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 44, doi. 10.3816/CLML.2011.n.005
- By:
- Publication type:
- Article
Pomalidomide‐dexamethasone for treatment of soft‐tissue plasmacytomas in patients with relapsed / refractory multiple myeloma.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 5, p. 389, doi. 10.1111/ejh.13217
- By:
- Publication type:
- Article
Bortezomib/dexamethasone followed by autologous stem cell transplantation as front line treatment for light-chain deposition disease.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 4, p. 340, doi. 10.1111/j.1600-0609.2012.01821.x
- By:
- Publication type:
- Article
Cytoplasmic inclusions in leukocytes associated to cryoglobulinemia and IgG-kappa monoclonal gammapathy of undetermined significance.
- Published in:
- European Journal of Haematology, 2011, v. 86, n. 6, p. 550, doi. 10.1111/j.1600-0609.2011.01584.x
- By:
- Publication type:
- Article
Extensive soft-tissue involvement by plasmablastic myeloma arising from displaced humeral fractures de Larrea et al. Bilateral plasmablastic myeloma arising from humeral fractures.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 5, p. 448, doi. 10.1111/j.1600-0609.2010.01504.x
- By:
- Publication type:
- Article
Generalized cutis laxa and fibrillar glomerulopathy resulting from IgG Deposition in IgG-lambda Monoclonal Gammopathy: pulmonary hemorrhage during stem cell mobilization and complete hematological response with bortezomib and dexamethasone therapy.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 2, p. 154, doi. 10.1111/j.1600-0609.2008.01181.x
- By:
- Publication type:
- Article
Spontaneous rupture of the spleen as immediate complication in autologous transplantation for primary systemic amyloidosis.
- Published in:
- European Journal of Haematology, 2008, v. 80, n. 2, p. 182, doi. 10.1111/j.1600-0609.2007.01005.x
- By:
- Publication type:
- Article
Long-term results of thalidomide in refractory and relapsed multiple myeloma with emphasis on response duration.
- Published in:
- European Journal of Haematology, 2006, v. 77, n. 6, p. 486, doi. 10.1111/j.0902-4441.2006.t01-1-EJH2783.x
- By:
- Publication type:
- Article
Bortezomib: an effective agent in extramedullary disease in multiple myeloma.
- Published in:
- European Journal of Haematology, 2006, v. 76, n. 5, p. 405, doi. 10.1111/j.0902-4441.2005.t01-1-EJH2462.x
- By:
- Publication type:
- Article
Development of rapidly progressive liver light chain deposition under VAD chemotherapy in multiple myeloma.
- Published in:
- European Journal of Haematology, 2006, v. 76, n. 1, p. 83, doi. 10.1111/j.1600-0609.2005.00561.x
- By:
- Publication type:
- Article
Risk of relapse and clinico-pathological features in 103 patients with diffuse large-cell lymphoma in complete response after first-line treatment.
- Published in:
- European Journal of Haematology, 1998, v. 61, n. 1, p. 59, doi. 10.1111/j.1600-0609.1998.tb01062.x
- By:
- Publication type:
- Article
Smoldering multiple myeloma and monoclonal gammopathy of undetermined significance.
- Published in:
- Current Treatment Options in Oncology, 2006, v. 7, n. 3, p. 237, doi. 10.1007/s11864-006-0016-7
- By:
- Publication type:
- Article
Combined Pegylated Liposomal Doxorubicin and Bortezomib Is Highly Effective in Patients With Recurrent or Refractory Multiple Myeloma Who Received Prior Thalidomide/Lenalidomide Therapy.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 7, p. 1529, doi. 10.1002/cncr.23326
- By:
- Publication type:
- Article
Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced hodgkin disease.
- Published in:
- Cancer (0008543X), 2000, v. 88, n. 9, p. 2142, doi. 10.1002/(SICI)1097-0142(20000501)88:9<2142::AID-CNCR21>3.0.CO;2-M
- By:
- Publication type:
- Article